Skip to main content

Table 3 Effects of Isoniazid prophylaxis on all cause mortality

From: Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta–analysis

Study

HIV status of participants

Participant ages

Risk ratio(95% CI)

p value

Madhi et al. (2011) [19]

Positive

<4 months(median 96 days, range 91–120 days)

1.00(0.68,1.48)

0.986

Madhi et al. (2011) [19]

Negative

<4 months(median 96 days, range 91–120 days)

0.90(0.49,1.65)

0.733

Zar et al. (2007) [18]

Positive

<51 months (median 24.7 months, IQR 9.4–51.6 months)

0.46(0.22,0.95)

0.015

Egsmose [20]

Negative

0–15 years

0.94(0.33,2.66)

0.91

All four studies combined

  

0.86(0.63,1.17)

0.168

Excluding studies that INH was initiated at age 4 months

  

0.58(0.31, 1.09)

0.092